Home > Insider Trading > Filing (0001209191-20-032416)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1531048	Inari Medical Inc.	NARI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1225480	D Jonathan Root	C/O Inari Medical, Inc. 9 Parker, Suite 100 Irvine CA 92618		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-27	251,795	$19.00	251,795	No	4	P	Direct
Common Stock	Acquisiton	2020-05-27	7,485,349	$0.00	7,485,349	No	4	C	Indirect	Directly Owned by USVP X
Common Stock	Acquisiton	2020-05-27	239,467	$0.00	239,467	No	4	C	Indirect	Directly Owned by AFF X

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Indirect	Directly Owned by USVP X
No	4	C	Indirect	Directly Owned by AFF X

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Acquisiton	2020-05-27	8,947	$0.00	8,947	$0.00
Common Stock	Series A Preferred Stock	Disposition	2020-05-27	2,307,142	$0.00	2,307,142	$0.00
Common Stock	Series A Preferred Stock	Disposition	2020-05-27	73,809	$0.00	73,809	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-05-27	2,899,876	$0.00	2,899,876	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-05-27	92,771	$0.00	92,771	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-05-27	2,278,331	$0.00	2,278,331	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-05-27	72,887	$0.00	72,887	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,947	No	4	A	Direct
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect

Footnotes

Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis.
The reported securities are owned directly by each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates Fund, L.P. ("AFF X") (together, the "USVP X Funds"). Presidio Management Group X, L.L.C. ("PMG X") is the general partner of each of the USVP X Funds and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds. Jonathan D. Root, a director of the issuer, Irwin Federman, Steven Krausz, Richard Lewis, Paul Matteucci and Casey Tansey are the managing members of PMG X, who may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds. Such persons and entities disclaim beneficial ownership of the reported securities held by the USVP X Funds, except to the extent of any pecuniary interest therein.3. The restricted stock unit vests in three equal annual installments beginning on May 27, 2020.
The restricted stock unit vests in three equal annual installments beginning on May 27, 2020.